January Newsletter
What to expect from Golden Helix in 2021

What to expect from Golden Helix in 2021
By Andreas Scherer, Ph.D. 
President & CEO

Happy New Year! I hope you had an opportunity to relax over the holidays with your family and friends. It’s time to start talking about our plans for the New Year, but first, please allow me to review a few highlights from 2020 that helped build a foundation for our future. Growth: Golden Helix was named to the 2020 Inc…

Read More

New eBook Update: Precision Medicine – Third Edition

New eBook Update: Precision Medicine – Third Edition
By Andreas Scherer, Ph.D. 
President & CEO

I am pleased to share with you the official release of my updated eBook, “Precision Medicine“. Almost 2,500 years ago, Hippocrates captured one of the key principles underlying precision medicine. In the 21st century, we take an understanding of the individual characteristics of a person to a new level. By leveraging information about an individual’s genome, we are able to…

Read More

Golden Helix Featured in Numerous Publications 2020

Golden Helix Featured in Numerous Publications 
By Dana Odenbeck
Sales & Marketing Associate

Golden Helix continues to innovate and grow, and due to this, we have been garnering attention and praise. We are thrilled to share with you some of the accolades and interest from numerous publications from the last six months. Talking points ranged from diagnosing and tracking Covid-19 infections leveraging NGS to new workflows, interpreting and reporting on copy number variants…

Read More

ACGS Guidelines Now Available in VSClinical

ACGS Guidelines Now Available in VSClinical
By Eli Sward, Ph.D
Field Application Scientist Manager

Golden Helix offers a market-leading bioinformatics solution that allows users to evaluate next-generation sequencing variants according to the ACMG and now ACGS guidelines. The ACMG guidelines were created in 2015 and are widely accepted as best practice for the interpretation of sequencing variants throughout the United States (Richard et al 2015). Very similar are the ACGS guidelines that were developed…

Read More

CEO Corner
Andreas Scherer, PhD

Happy New Year to the Golden Helix Community! We are very grateful for the support our customers and partners have given us over the last two decades, and especially throughout 2020. We are looking forward to another innovative year for our company, which I have outlined in a recent blog post “What to Expect from Golden Helix in 2021”. Last week, I also released a new version of my eBook “Precision Medicine” which I invite you to download a free copy of here. We have a lot of excitement ahead of us which I will keep you up to date on. In the meantime, I wish you a prosperous year as well and look forward to staying in touch throughout 2021.

On-Demand Webcast

VSClinical: a complete clinical workflow solution

VSClinical is a single testing paradigm that consolidates and automates the tertiary analysis workflow. With this software, users can perform variant and sample QC, create a variant evaluation using a plethora of public and licensed annotation sources and evaluate variants with the automated ACMG and AMP guidelines for SNVs, Indels, and CNVs. All this information can then be used to create a clinical report with our new word-based report templates. In this webcast, we plan to demonstrate the full clinical analysis workflow within VSClinical...

Access the Recording
Customer Publications

Congratulations to all of our customers who have published this month! To highlight just a few:

Bi-Allelic Pathogenic Variations in MERTK Including Deletions are Associated with an Early Onset Progressive Form of Retinitis Pigmentosa - Cathrine Jespersgaard, Lisbeth Birk Moller & Colleagues, University of Copenhagen / Published in Genes

A Mutational Repertoire of Uterine Sarcomas and Carcinosarcomas in a Brazilian Cohort: A Preliminary Study - Dirce Carraro & Colleagues, A.C. Camarago Hospital, Brazil / Published in Clinics

Read the full list of featured articles published this month on our blog!

About Golden Helix

Golden Helix has been delivering industry-leading bioinformatics solutions for the advancement of life science research and translational medicine for over 20 years with 1,000s of users around the world. Their innovative technologies and analytic services empower scientists and healthcare professionals at all levels to derive meaning from the rapidly increasing volumes of genomic data produced from NGS sequencers and microarrays. With their solutions, hundreds of the world's top hospitals, testing labs, pharmaceutical, biotech, and academic research organizations can harness the full potential of genomics to identify the cause of disease, improve the efficacy and safety of drugs, develop genomic diagnostics, and advance the quest for personalized medicine.